| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.53 | 0.0006 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |